secwatch.observer — SEC 8-K summary
======================================

Issuer:     UNITEDHEALTH GROUP INC (UNH)
CIK:        0000731766
Form:       8-K
Filed at:   2026-07-16T10:00:59+00:00
Accession:  0000731766-26-000191
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

UnitedHealth Q2 2026 EPS $6.04 GAAP, $6.38 adjusted; raises full-year guidance
------------------------------------------------------------------------------

- Q2 revenues $112.0B (flat YoY); earnings from operations $8.0B vs $5.2B in Q2 2025.
- GAAP EPS $6.04, adjusted EPS $6.38; medical cost ratio improved to 86.7% from 89.4%.
- UnitedHealthcare operating margin 4.6% (vs 2.4% YoY); Optum margin 6.2% (vs 4.6%).
- Full-year adjusted EPS guidance raised to $19.50-$20.00 from prior >$17.75; cash flow ops guidance ~$24B.
- Share repurchase target increased to at least $5B for 2026; debt-to-capital ratio 41.2%.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/731766/000073176626000191/0000731766-26-000191-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/731766/000073176626000191/unh-20260716.htm
  HTML page:      https://secwatch.observer/filing/0000731766-26-000191

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer